Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Active not recruiting 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 1Peritoneal Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mesothelioma 1Hepatoblastoma 1Chemotherapeutic Agent Toxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Nivolumab 2Docetaxel 2tivozanib 1gallium 68 PSMA-11 1atezolizumab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Specimen Handling 1Paclitaxel 1Oxycodone 1Menogaril 1Magnetic Resonance Imaging 1Ketorolac 1Ketamine 1Interleukin-2 1Genome 1Genetic Testing 1Etoposide 1Cisplatin 1Carboplatin 1CYT003-QbG10 1Biopsy 1Acetaminophen 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × Cisplatin × Clear all
NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡